DAY 3 Irish Biotech leads the way

Standard

DAY 3 Irish Biotech leads the way

Heart Metabolics completes $20M Series A funding to bring drugs on the market for Hypertrophic

cardiomyopathy (HCM) and other cardio-metabolic diseases. Read more here

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s